Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: beta-2 adrenergic agonists.
AMYOTROPHIC LATERAL SCLEROSIS(2009)
Abstract
ALS/MND therapeutics will require juxtaposition in the patient of 1. primary treatments to mitigate the underlying pathogenesis of ALS/MND, 2. adjuvant treatments to stop propagating events trying to maximize survival, strength and function, and 3. symptomatic treatments to minimize symptoms and complications resulting from ALS/MND (Figure 1). Little attention has been paid to the strategies to develop mosaic therapeutic approaches in ALS/MND and how to evaluate efciently the potential efcacy and safety of mosaic therapies.
MoreTranslated text
Key words
mosaic chemotherapy strategies,als/mnd,therapeutic approaches
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined